 |
Page History
This page provides an overview of the changes in CTRP. For any questions or issues regarding these feature enhancements, please contact the CTRO (NCICTRO@mail.nih.gov).
March 2021
Updatesto the Data Table 4 (DT4) Anatomic Site values displayed on the CTRP-generated DT4 report:
Previous DT4 Anatomic Site Value | Updated DT4 Anatomic Site Value |
Leukemia, not otherwise specified | Leukemia, other |
Breast – Female | Breast |
Breast – Male | Breast |
Hodgkin's Lymphoma | Hodgkin Lymphoma |
Non-Hodgkin's Lymphoma | Non-Hodgkin Lymphoma |
Soft Tissue / Sarcoma | Soft Tissue |
Note: For trials with numerous “Primary Sites” (DT4 Anatomic Sites), the value “Multiple” for the DT4 Anatomic Site Code will be used and displayed on the CTRP-generated DT4 report. All existing trials in CTRP have been updated to reflect this change as well.
For a complete list of DT4 anatomic site values displayed on the CTRP-generated DT4 report, please visit this CTRP User Guide page:
https://wiki.nci.nih.gov/display/CTRPdoc/Data+Table+4+Anatomic+Site+Values
Removal of the following fields from the Trial Summary Report (TSR):
- Keywords
- Program Code in the Data Table 4 Section
- Target Accrual in the Participating Site Section
- Reporting Data Set Method
September 2020
CTRP Trial Record Verification: Improved the user experience for CTRP trial owners, trial submitters and site administrators with Verifying, Updating and/or Amending their trial records. Key highlights from this enhancement include:
...
